After completing his Ph.D., Michael Chen did a postdoctoral position in the Dept of Psychiatry at the University of Mississippi Medical Center under the supervision of Dr. John Piletz. There, he started his studies centering around the molecular aspects of depression, focusing on imidalzoline receptors. Following this 3-year appointment, Dr. Chen moved to the laboratory of Dr. Amelia Russo-Neustadt, Dept of Biological Sciences, California State University, Los Angeles (CSULA), where he continued his molecular studies of depression, focusing on the role of antidepressants and exercise on brain-derived neurotrophic factor (BDNF) as a neuronal signaling mediator of cell survival cascades, such as the ERK and Akt pathways, and CREB. Currently, for the past 2-3 years, he has served as a lecturer, teaching upper-division courses in neuroscience, endocrinology, toxicology, pharmacology, and physiology in the Dept of Biological Sciences at CSULA. Areas of expertise are: neuropharmacology, neurosciences, endocrinology.
Biography Updated on 1 April 2012